BioSpace.com News

AOP Orphan Pharmaceuticals AG Spins Off Its Stake in Activartis Biotech GmbH and Outlines Business Strategy

Mon, 17 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Vienna, Austria, June 17, 2013 / B3C newswire / - AOP Orphan Pharmaceuticals AG today announced the spin off of its 80 % stake in Activartis GmbH, a Vienna-based biotech company with a strong platform for immune...

CoMentis, Inc. and Announce Formation of a Joint Venture to Explore Nicotinic Modulators

Fri, 14 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CoMentis and Anvyl Announce Formation of Alpharmagen, a Joint Venture to explore Nicotinic Modulators

SOUTH SAN FRANCISCO, Calif., June ...

Emory University to Launch New Therapeutics

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Drug development venture links research, business to launch new therapeutics

Emory University today announced an innovative new public-private drug development enterprise...

Zenith Epigenetics Corp. Commences Operations

Tue, 04 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CALGARY, June 3, 2013 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith") commenced operations today...

Pfizer Inc. to Spin Off Remaining Zoetis Stake in Exchange Offer

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Pfizer Announces Plan for Split-Off of Zoetis

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (PFE) today announced its intention to split off its remaining interest in Zoetis...

Roche and Team Up to Launch Successful Startups in the Bay Area

Mon, 20 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Roche and QB3 Team Up to Launch Successful Startups in the Bay Area

Basel, Switzerland and Seattle, WA, USA May 16, 2013 -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and the...

Bayer HealthCare Goes on a Startup Hunt

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Bayer HealthCare has a matchmaker in QB3. Now it's formalizing that arrangement. The global drug giant announced Wednesday that it signed a three-year deal with the University of California institute and seed...

Atlas Venture Leans on Amgen, Novartis AG to Build New Startups

Thu, 16 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Fresh off raising $265 million to bankroll its ninth fund, Atlas Venture has forged strategic partnerships with Amgen and Novartis to help supply the bigger companies with innovative new drug candidates. The...

Pfizer Inc. Reviews Idea of Splitting Up

Thu, 02 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Pfizer Inc. (PFE), the worlds biggest drugmaker, will analyze over the next eight months whether it will split itself into brand name and generics businesses, Chief Financial Officer Frank DAmelio said...

InCube Labs Launches Two New Life Sciences Companies in San Antonio

Thu, 02 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN ANTONIO and SAN JOSE, Calif., May 2, 2013 /PRNewswire/ -- InCube Labs, a life...

Harvard Bioscience Inc. Affirms Plan to Spin-Off and Announces Its Intended Path Forward

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HOLLISTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative...

Resverlogix Corporation's Board Approves Arrangement to Spin-Out RVX Therapeutics Inc. and Confirms Special Meeting of Shareholders

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TSX Exchange Symbol: RVX

CALGARY, May 1, 2013 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) ("Resverlogix...

Theravance, Inc. to Split Into Drug Development, Royalty Companies

Mon, 29 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SOUTH SAN FRANCISCO, CA--(Marketwired - April 25, 2013) - Theravance, Inc. (NASDAQ: THRX)

Intention...

Resverlogix Corporation to Spin-Out RVX Therapeutics Inc.

Mon, 08 Apr 2013 12:00:00 AM GMT

Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform

TSX Exchange Symbol: RVX

CALGARY, April 8, 2013 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) ("Resverlogix") today announced that its Board of Directors has approved...

Former Tokai Pharmaceuticals CEO Co-Founds Startup Focused on Alzheimer's

Fri, 05 Apr 2013 12:00:00 AM GMT

The former CEO of cancer drug company Tokai Pharmaceuticals, Inc. in Cambridge, Mass., Martin Williams, told Mass High Tech he will be working to build a new company he co-founded aimed at neurodegenerative and Alzheimers disease. Tokai announced last week that Williams had stepped down from his role as CEO but declined to say where he went when asked by Mass High Tech. Williams had taken over as...

Harvard Bioscience Inc. Announces Receipt of Private Letter Ruling and Affirms Plan to Spin-Off Following Its Initial Public Offering

Mon, 25 Mar 2013 12:00:00 AM GMT

HOLLISTON, Mass., March 25, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has received a private letter ruling from the Internal Revenue Service that subject to certain conditions, the anticipated spin-off of Harvard Apparatus Regenerative...

Pfizer Inc. Spinoff No Need for Worry in Groton, Conn.: Analyst

Wed, 16 Jan 2013 12:00:00 AM GMT

A news report Tuesday that Pfizer Inc. could be split into two companies in the next few years shouldnt necessarily concern scientists at the companys laboratories in Groton, according to a health care firm analyst. Les Funtleyder, president of the investment advisory division of New York-based Poliwogg Inc., said a report by Bloomberg news service that sparked speculation Pfizer might soon cut itself...

Oculus Innovative Sciences, Inc. Announces Plan to Spin Off Biotechnology Business

Thu, 10 Jan 2013 12:00:00 AM GMT

PETALUMA, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that its board of directors has unanimously approved a spin-off of its novel biotechnology business, Ruthigen, Inc.

Oculus management is currently working with securities counsel and bankers on a plan to provide equity in Ruthigen to Oculus shareholders. Oculus expects the...

GlaxoSmithKline Says No Plan for ViiV Healthcare Spinoff "at the Moment"

Thu, 10 Jan 2013 12:00:00 AM GMT

GlaxoSmithKline Plc (GSK) has no plans at the moment to spin off its ViiV Healthcare Ltd. unit that is developing drugs to treat HIV, said Patrick Vallance, Glaxos president of pharmaceuticals research and development. ViiV exists as a standalone company of which we are majority shareholders, he said in an interview in San Francisco, where he was attending JPMorgan Chase & Co.s health- care investment...

Prothena of SSF Gets Head Start as Elan Corporation PLC Spinoff

Wed, 09 Jan 2013 12:00:00 AM GMT

The whole is greater than the sum of its parts, goes the famous quote attributed to Aristotle. But biotechnology company Elan didnt see it that way when it split up its business units recently. In late December, Elan (NYSE: ELN) of Dublin, Ireland spun off its early stage drug discovery unit, now named Prothena, (NASDAQ: PRTA). Elan concluded that the two separated companies would each be worth...

Neurotechnology Launches SkyBiometry Spin-off Company to Deliver SaaS Biometric Identification and Feature Analysis

Wed, 12 Dec 2012 12:00:00 AM GMT

VILNIUS, Lithuania, Dec. 12, 2012 /PRNewswire/ -- SkyBiometry, a new company providing cloud-based biometric software as a service (SaaS), was officially launched today as a spin-off of Neurotechnology...

APEIRON Biologics AG Establishes Biotech-Spinoff

Tue, 04 Dec 2012 12:00:00 AM GMT

Vienna, 4 December 2012: APEIRON Biologics AG (Apeiron) today announced the launch of Attoquant Diagnostics GmbH (Attoquant) as a subsidiary. Attoquant will globally commercialize its already successfully marketed peptide analytics service RAS-FingerprintTM and further develop the underlying platform technology.

Vienna-based biotech company APEIRON Biologics AG (Apeiron) today announced the...

Caliber Biotherapeutics and ImmunGene, Inc. Launch

Wed, 14 Nov 2012 12:00:00 AM GMT

THOUSAND OAKS, Calif. and BRYAN, Texas, November 13, 2012 /PRNewswire-iReach/ -- ImmunGene, Inc. (ImmunGene) and Caliber Biotherapeutics, LLC (Caliber) announced today the launch of Valor Biotherapeutics, LLC (Valor), a joint venture focused on the clinical development and commercialization of monoclonal antibody-interferon (mAb-IFN) fusion protein therapeutics targeting certain cancers. The mAb...

BioTime and Subsidiary LifeMap Sciences Announce the Launch of LifeMap BioReagents™ Portal

Wed, 14 Nov 2012 12:00:00 AM GMT

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences have announced the launch of LifeMap BioReagents (http://bioreagents.lifemapsc.com/), a new portal offering researchers access to BioTimes research product lines including PureStem human progenitor cell lines, PureStem packages, clinical and research grade human embryonic stem cell lines (hES), HyStem...

Yissum Ltd. Announces Formation of a Biopharmaceutical Holding Company

Wed, 31 Oct 2012 12:00:00 AM GMT

Integra Holdings closes U.S. $7.0 million private financing -

JERUSALEM--(BUSINESS WIRE)--Yissum Research and Development Company of the Hebrew University of Jerusalem, the technology transfer company of the Hebrew University, announced today the inception of its subsidiary, Integra Holdings, a holding company focusing on biopharmaceutical companies based on inventions of researchers from...

Amgen Closes Deal With Financial Firm to Open New Biotech Company

Mon, 29 Oct 2012 12:00:00 AM GMT

Amgen | Jobs at Amgen

Amgen and Kleiner Perkins Caufield & Byers (KPCB) have founded a new drug development firm, Atara Biotherapeutics, focused on chronic...

Roche Bankrolls R&D in New Biotech Startup

Fri, 12 Oct 2012 12:00:00 AM GMT

Inception Sciences, the discovery-stage biotech firm-slash-incubator created from the ground up to spin out assets in a buyer-friendly manner, has its first pharma partner. The San Diego firm has created a spin-off dubbed Inception 3 that will house a technology platform from Stanford University and develop drugs to treat permanent hearing loss. Roche is the partner, pledging R&D funds via undisclosed...

Drug Development Company Formed Following Completion of CBio Limited M&A Transaction

Wed, 05 Sep 2012 12:00:00 AM GMT

BRISBANE, 31 AUGUST 2012: Australian drug development company CBio Limited (ASX:CBZ) is pleased to advise that the merger with US based Inverseon Inc. has been successfully completed.

Dr William Garner has been appointed Managing Director and Chief Executive Officer of Invion Limited, and Dr Mitchell Glass has been appointed Executive Vice President of R&D and Chief Medical...

Ex-Google Inc. Workers Start to Help Fight Cancer

Tue, 28 Aug 2012 12:00:00 AM GMT

Nat Turner and Zach Weinberg have both watched family members suffer from cancer. So when they left Google in June, they started brainstorming ways to help find a cure. Turner and Weinberg aren't doctors, but they're engineers with deep pockets. When they were 24, they sold their startup, Invite Media, to Google for $81 million. After their June brainstorming session, the two began meeting with dozens...

Pharmatek Laboratories, Inc. Establishes the

Tue, 28 Aug 2012 12:00:00 AM GMT

SAN DIEGO, Aug. 28, 2012 /PRNewswire/ -- Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization (CDMO) has created the Pharmatek Foundation, a not-for-profit organization supporting volunteerism for causes in the San Diego community. The Foundation's mission is to encourage and support sponsored...

Phenomenex, Inc. Forms Phenova - a Certified Reference Materials Company

Wed, 22 Aug 2012 12:00:00 AM GMT

Torrance, CA (August 22, 2012) - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the creation of a new company - Phenova, Inc. - which culminates the integration and expansion of Colorado-based Wibby Environmental. Phenova provides proficiency standards and testing services to environmental laboratories working under strict...

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, Creates Itonis Pharmaceuticals, a New Division of Itonis, Inc.

Thu, 16 Aug 2012 12:00:00 AM GMT

IRVINE, CA--(Marketwire - August 16, 2012) -

Highlighted Links

Itonis website

Itonis, Inc. (PINKSHEETS: ITNS) and Charles...

Elan Corporation PLC Fuels Buyout Plans With $130 Million R&D Spinout, Unit Will Have Around 80 Staffers

Tue, 14 Aug 2012 12:00:00 AM GMT

Ireland's Elan (ELN.I) said on Monday it would spin off its Neotope drug discovery business platform as a separate public company in a move making Elan immediately profitable. The decision to split the company comes hard on the heels of the failure of an experimental Alzheimer's drug being developed with Pfizer (PFE.N) and Johnson & Johnson (JNJ.N), although Chief Executive Kelly Martin said it had...

Parkinson's Specialist Spins Out From Merck Serono's Soon-to-close R&D Operations

Mon, 30 Jul 2012 12:00:00 AM GMT

GENEVA, July 30, 2012 /PRNewswire/ --

Prexton Therapeutics Will Develop Merck Serono's Metabotropic Glutamate Receptors Programs for Parkinson's Disease

Merck Serono, a division of Merck, Darmstadt, Germany, announced today the creation of Prexton Therapeutics, the first spin-off company resulting from its Entrepreneur Partnership Program launched in April 2012. Prexton Therapeutics...

Pfizer Inc. Spinning Off Animal Health Biz, New Co. Will be Called Plans IPO

Fri, 08 Jun 2012 12:00:00 AM GMT

NEW YORK, Jun 07, 2012 (BUSINESS WIRE) -- --Standalone Company to Be Called Zoetis(TM)

Pfizer Inc. today announced the next steps in the strategic alternatives review process for the company's Animal Health business. Preparations are underway to file a registration statement in the U.S. for a potential initial public offering (IPO) of a minority ownership stake in the new company. Pfizer...

Galena Biopharma Takes Final Actions to Complete Spin-Off of RXi Pharmaceuticals

Thu, 26 Apr 2012 12:00:00 AM GMT

LAKE OSWEGO, Ore., April 26, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (GALE - News), a biotechnology company focused on developing innovative, targeted oncology treatments, announced today that it has initiated the final steps to complete the previously announced spin-off of RXi Pharmaceuticals Corporation, Galena's wholly-owned subsidiary. To effectuate the spin-off, Galena is paying a dividend...

Janssen Pharmaceutica N.V. Creates New Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Thu, 19 Apr 2012 12:00:00 AM GMT

BEERSE, Belgium, April 19, 2012 /PRNewswire/ --

Today sees the launch of Janssen Therapeutics EMEA, a division of Janssen Pharmaceutica NV, dedicated to bringing the investigational protease inhibitor TMC435 to hepatitis C patients in the EMEA region.

Approximately 130-210 million people are infected...

Fujifilm Kyowa Kirin Biologics Launches, Joint Venture of FUJIFILM Holdings Corporation and Kyowa Hakko Kirin for the Development, Manufacturing and Sales of Biosimilars

Tue, 27 Mar 2012 12:00:00 AM GMT

Tokyo, Japan, March 27, 2012 --- FUJIFILM Corporation (President and CEO Shigetaka Komori; hereinafter "Fujifilm") and Kyowa Hakko Kirin Co., Ltd. (President and CEO Nobuo Hanai; hereinafter "Kyowa Hakko Kirin") commenced business operations of the "FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd." (President and CEO Hideaki Nomura; hereinafter "Fujifilm Kyowa Kirin Biologics"), a joint-venture for the development...

Veteran Pharmaceutical Executives Launch

Tue, 27 Mar 2012 12:00:00 AM GMT

NASHVILLE, Tenn., March 26, 2012 /PRNewswire/ -- Pharmaceutical industry veterans Al Dampier and Jim Aderhold today announced the launch of Dampier Consulting Group (DCG), a life sciences consulting...

Deals Worth $1.75 Billion Offer Insight into Abbott Laboratories's Spinoff Strategy

Mon, 19 Mar 2012 12:00:00 AM GMT

Recent acquisitions underscore the Abbott's determination to augment the new firm's drug pipeline ahead of the spin, even if it comes at a hefty price with little guarantee the investments will pay off. Before Abbott Laboratories officially lops off its legacy pharmaceutical business into a separate publicly traded enterprise, it's making an effort to restock the shelves to strengthen the spinoff company...

Vitrolife Preparing Distribution of the Transplantation Business

Mon, 19 Mar 2012 12:00:00 AM GMT

GTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

Vitrolife AB (publ)(STO:VITR) is today publishing the decision of the Board to begin preparations for a spin-off of the transplantation business, which today is run in the subsidiary Xvivo Perfusion AB. The spin-off will take place through distribution of the shares in the subsidiary in accordance with Lex Asea. It is intended that the...

University of Pennsylvania Biotech Spinout Receives Support From Science Center New Ventures Program, Takes Office and Lab Space at Port Business Incubator

Mon, 12 Mar 2012 12:00:00 AM GMT

PHILADELPHIA, March 12, 2012 (GLOBE NEWSWIRE) -- A biotech company formed out of the University of Pennsylvania with the support of the University City Science Center is one of two new companies to locate in the Port Business Incubator. Nelum Sciences, a spin out of the University of Pennsylvania's School of Engineering, is occupying lab space while Oxo Pharma, headquartered in France, has established...

Cardiff University Medical Spin-out Secures ??292,000

Wed, 29 Feb 2012 12:00:00 AM GMT

Cardiff-based medical instruments company Asalus has completed the first closing of a funding round set to reach almost 700,000 in two tranches. The deal, backed by regional fund Finance Wales and intellectual property commercialisation firms IP Group and Fusion IP, will facilitate the trial of a new device to clear the smoke arising from surgical procedures. The device, produced under the name Innervision...

Caxton Advantage Venture Partners Announces Formation of Valence Life Sciences

Fri, 24 Feb 2012 12:00:00 AM GMT

NEW YORK and SAN DIEGO, Feb. 23, 2012 /PRNewswire/ -- Caxton Advantage Venture Partners, L.P. ("Caxton Advantage"), the life sciences venture capital firm founded in 2006 by Dr. Rachel Leheny, Eric...

Former Pfizer Inc. Employees Creates Firm for Working With CROs

Fri, 24 Feb 2012 12:00:00 AM GMT

A year ago, Pfizer announced a plan to exit its research and development site in Sandwich in southern England over the course of 2 years. At the time of the announcement, the site employed about 2400 workers. The company later announced that it would downsize the site instead of closing it. According to recent reports, 1500 employees will lose their jobs by the end of 2012 and 250 will be transferred...

Quintiles, Inc. Takes Stake in UK Biomarker Startup

Wed, 18 Jan 2012 12:00:00 AM GMT

Professors David Kerr and Nick La Thangue offer oncology consulting and biomarker R&D activities spun out from the University of Oxford

OXFORD, U.K. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Continuing its commitment to advancing personalized medicine by offering world-leading experts and cutting-edge tools, Quintiles today announced that it has invested in a new company formed to...

Warp Drive Bio Launches With $125 Million from Third Rock Ventures, Greylock, Sanofi (France)

Tue, 10 Jan 2012 12:00:00 AM GMT

BOSTON & CAMBRIDGE, Mass., Jan 10, 2012 (BUSINESS WIRE) -- Third Rock Ventures and Warp Drive Bio today announced the launch of the new company and its broad strategic partnership with Sanofi /quotes/zigman/187275 FR:SAN 1.72% /quotes/zigman/307926/quotes/nls/sny SNY 1.23% , which positions the companies to transform the discovery and development of natural product drugs using Warp Drive Bio's proprietary...

MonoSolRx LLC and Midatech Group Launch

Thu, 05 Jan 2012 12:00:00 AM GMT

Strategic Initiative Focused on Partnering/Licensing of Innovative Diabetes Therapies

Combines MonoSol Rx' Proprietary PharmFilm and Midatech's Proprietary MidaForm Nanoparticle Technologies

WARREN, N.J. and OXFORD, UK, Jan. 5, 2012 (GLOBE NEWSWIRE) -- MonoSol Rx LLC, the developer of PharmFilm drug delivery technology, and Midatech Ltd., the developer of MidaForm nanoparticle...

Smith & Nephew Inc. Spins Off Biologics Unit Into JV With Essex Woodlands Health Ventures

Wed, 04 Jan 2012 12:00:00 AM GMT

HOUSTON, TX--(Marketwire -01/04/12)- Essex Woodlands (www.ewhv.com), a global healthcare growth equity and venture capital firm, announced today a strategic partnership with Smith & Nephew (http://global.smith-nephew.com/master/6600.html), the largest UK-based medical device company, to fund the spinout of Smith & Nephew's Biologics and Clinical Therapies division and develop a leading global orthopedic...

Provectus Pharmaceuticals Inc. and its Subsidiaries Complete Unregistered Offering of Units to Facilitate Spin-off of

Tue, 20 Dec 2011 12:00:00 AM GMT

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced today that it and its five wholly owned subsidiaries, Pure-ific Corporation, Provectus Biotech, Inc., Provectus Devicetech, Inc., Provectus Imaging, Inc., and Xantech Pharmaceuticals, Inc. (the Subsidiaries), have...

VHGI Holdings, Inc. Announces Intent to Spin-Out Medical Office Software Subsidiary

Mon, 19 Dec 2011 12:00:00 AM GMT

FT. WORTH, Texas, Dec. 19, 2011 /PRNewswire/ -- VHGI Holdings, Inc. (OTC.QB: VHGI) announced today that it intends to distribute to the shareholders of VHGI Holdings all of its ownership interest in Medical Office Software, Inc., a Florida corporation ("MOS"), which will result in MOS being a separately traded publicly-held company...

Covidien plc Plans Spin-off of Pharmaceuticals Business

Thu, 15 Dec 2011 12:00:00 AM GMT

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV), a leading global provider of healthcare products, today announced that it plans to spin off its pharmaceuticals business into a standalone public company.

Covidiens pharmaceuticals business is one of the worlds largest producers of bulk acetaminophen, the largest United States supplier of opioid pain medications and is among the top ...

BioTrak Research Inc. Spins Out Patient Recruiters International, Inc.

Wed, 09 Nov 2011 12:00:00 AM GMT

CARLSBAD, CA Nov. 1, 2011 BioTrak Research Inc., a specialty contract research organization announced today the launch of a wholly owned affiliate, Patient Recruiters International, Inc. (PRI), a full-service patient recruitment organization.

The launch of PRI is a direct response to the increasing demand for qualified research subjects in the clinical research field. With patient recruitment...

Karo Bio AB Prepares Spin-off of Preclinical Development

Tue, 25 Oct 2011 12:00:00 AM GMT

HUDDINGE, Sweden--(BUSINESS WIRE)-- Regulatory News: Karo Bio AB (publ) is preparing a better allocation of resources and competences by spinning off the companys preclinical activities. This part will therefore be transferred into a subsidiary that is intended to become autonomous in operations as well as by ownership. The subsidiary will be proposed to assume the name Karo Bio.

Karo Bio...

Abbott Laboratories to Split Into 2 Companies

Fri, 21 Oct 2011 12:00:00 AM GMT

ABBOTT PARK, Ill., Oct. 19, 2011 /PRNewswire/ -- Today Abbott (NYSE: ABT) announced that it plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals. The diversified medical products company will consist of Abbott's existing diversified medical products portfolio, including its branded generic...

RBCC Forms New Division to Enter $84.6 Billion Biotechnology Sector

Thu, 20 Oct 2011 12:00:00 AM GMT

NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow Coral Corp. (OTCQB:RBCC) today announced the formation of a new divisionRainbow BioSciences, LLCto pursue new opportunities in the burgeoning global biotechnology sector.

The biotech industry has made tremendous gains recently, with all biotech ETFs significantly outperforming the S&P 500 over the last five years. The global biotech market, led by...

Blaze Bioscience Inc., Fred Hutchinson Cancer Research Center Spinoff with ZymoGenetics, Inc. Vet at the Helm, Seeks to "Paint" Tumors

Tue, 18 Oct 2011 12:00:00 AM GMT

Heather Franklin had a lot to think about in September 2010. She was a senior vice president at Seattle-based ZymoGenetics, when it agreed to be acquired by Bristol-Myers Squibb for $885 million. Now that the big company was calling the shots, it was time to think about a new move in her career. Jim Olson, a physician/scientist/entrepreneur at the Fred Hutchinson Cancer Research Center, sensed opportunity...

RXi Pharmaceuticals Plans to Split into Two Public Firms

Mon, 26 Sep 2011 12:00:00 AM GMT

RXi Pharmaceuticals Corp. /quotes/zigman/109669/quotes/nls/rxii RXII -12.84% said it plans to split into two publicly traded companies later this year, separating its oncology and gene therapy businesses. The biotechnology company will change its name to Galena Biopharma but will continue to trade under the ticker symbol RXII until the completion of the spinoff of RXi Pharmaceuticals. After the split...

Russia Takes Stake in Unusual British Drug Company; New Pharma Company Launches Today

Mon, 12 Sep 2011 12:00:00 AM GMT

MOSCOW and LONDON, September 12, 2011 /PRNewswire/ --

- Anglo/Russian Venture Will Have Important Humanitarian Objectives From Day 1

Pro Bono Bio is a new international pharmaceutical company that launched today. Pro Bono Bio is the result of a three year Anglo/Russian...

Panmira Pharmaceuticals, LLC. and Spun Out of Amira Pharmaceuticals, Inc.

Fri, 09 Sep 2011 12:00:00 AM GMT

SAN DIEGO, Sept. 8, 2011 /PRNewswire/ -- Panmira Pharmaceuticals, LLC and FLAP, LLC, today announced their formation around certain assets spun out immediately preceding the acquisition of Amira Pharmaceuticals, Inc. (Amira) by Bristol-Myers Squibb Company (NYSE: BMY). Panmira Pharmaceuticals received a number of assets, including Amira's DP2 antagonists, AM211 and AM461, both of which have successfully...

Former Pfizer Inc. Employees Start New Firm at Sandwich Site

Thu, 01 Sep 2011 12:00:00 AM GMT

A company set up by a group of former Pfizer employees is one of the the first businesses to be based at the east Kent site which Pfizer is leaving.

The Research Network, which employs seven former Pfizer workers, is operating from Discovery Park in Sandwich.

Allenex AB Spins off Novahep AB and Recopharma AB

Thu, 25 Aug 2011 12:00:00 AM GMT

STOCKHOLM--(BUSINESS WIRE)-- Allenex (STO:ALNX.st - News) transfers its holdings in the portfolio companies NovaHep AB and Recopharma AB to Alden Impact Capital AG, Zurich, who takes responsibility for the continued financing of their activities.

In NovaHep, focusing on liver stem cells, has Allenex been shareholder since 2005 and in Recopharma, with a focus on recombinant glyco proteins...

Cambridge Spin-out, MissionTherapeutics Ltd Raises $10 Million, Eyes Rapid Growth

Thu, 25 Aug 2011 12:00:00 AM GMT

25 August 2011 -- Imperial Innovations Group plc (AIM: IVO, Innovations, or the Group), the UKs leading technology commercialisation and investment company, has participated in a 6 million funding round into MISSION Therapeutics (MISSION), investing 1.3m. Sofinnova Partners led the round which also included SR One and Roche Venture Fund. Following the investment, Innovations will hold ...

inVentiv Health Launches Consolidated Communications Company in Europe

Wed, 24 Aug 2011 12:00:00 AM GMT

BURLINGTON, Mass., Aug. 24, 2011 /PRNewswire/ -- inVentiv Health, offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced the launch of inVentiv Health Communications/Europe, a new company that brings together inVentiv's advertising...

Noble Life Sciences Inc. Announces the Formation of Its Investment Group,

Thu, 30 Jun 2011 12:00:00 AM GMT

GAITHERSBURG, MD--(Marketwire - June 29, 2011) -

Highlighted Links

Noble Life Sciences

The founders of Noble Life Sciences announced today the formation of an investment capital fund...

Can-Fite BioPharma Signed an Agreement to Spin off Its Ophthalmology Activities to a US Based Public Company

Mon, 06 Jun 2011 12:00:00 AM GMT

PETAH-TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange, signed today an agreement to spin off its ophthalmic indications to a US based public company, Denali Concrete Management Inc. (OTC BB: DCMG.OB).

According...

New Company, Formed

Fri, 03 Jun 2011 12:00:00 AM GMT

Airway Therapeutics LLC has been created to commercialize pulmonary therapy research developed at Cincinnati Children's Hospital Medical Center and has received a $500,000 investment from CincyTech and Cincinnati Children's Tomorrow Fund.

The investments are part of a projected $1.2 million seed-stage funding round led by CincyTech.

CincyTech and the Tomorrow Fund each invested...

Caerus Discovery, LLC, New Biotechnology Company is Announced

Wed, 01 Jun 2011 12:00:00 AM GMT

Caerus Discovery was launched today to develop a novel platform for rapid discovery and development of therapeutic targets and biomarkers. Caerus was initiated with program support from BioWa, Inc and certain antibody technologies from Immunocellular Therapeutics, Ltd (OTCBB: IMUC).

We are very excited to employ our proprietary platform technology to discover novel disease biomarkers...

Eli Lilly and Company and Investor Group Form New Critical Care Company Sign Xigris License Agreement

Mon, 23 May 2011 12:00:00 AM GMT

Eli Lilly and Company (NYSE: LLY) today announced that it has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a newly-formed and privately-held biotechnology company. BioCritica, based in Central Indiana, will initially focus on the continued U.S. development and commercialization of Xigris (drotrecogin alfa...

Aurobindo Pharma Mulls Spinning Off Units

Tue, 10 May 2011 12:00:00 AM GMT

Drug maker Aurobindo Pharma is evaluating restructuring options including spinning off its active pharmaceutical ingredient and formulations unit in a bid to unlock value of an expanding segment of its business. The Hyderabad-based company made this announcement, and followed it with its results, which showed a net profit increase of 13% to 5.94 billion rupees ($132.94 million) for the year ended March...

Innate Pharma and TRANSGENE Announce the Creation of a New Company Specialized in Immunomonitoring Services

Wed, 04 May 2011 12:00:00 AM GMT

May 04, 2011 -- Innate Pharma (Euronext Paris: FR0010331421) and Transgene (Paris:TNG) (Euronext Paris: FR0005175080) - two biotechnology companies specialized in the development of innovative immuno therapeutics, announce the creation of Platine Pharma Services ( Platine ). Platine is a new immunomonitoring1 company providing fee-based services to the healthcare industry for the preclinical and...

New Biopharmaceutical Company, to Accelerate Delivery of Vaccines and Protein Therapeutics

Mon, 25 Apr 2011 12:00:00 AM GMT

BRYAN/COLLEGE STATION, Texas, April 25, 2011 /PRNewswire/ -- Caliber Biotherapeutics, a fully-integrated biopharmaceutical company, announced the opening of the world's largest plant-made pharmaceutical manufacturing facility in Bryan, Texas, with the capability of producing ...

Crystallics - a New Company Spinout with a Long History in Pharmaceutical Development

Tue, 19 Apr 2011 12:00:00 AM GMT

Amsterdam, The Netherlands, April 19, 2011 / B3C newswire / Avantium Pharma BV, a leader in solid state research and pre-formulation for the pharmaceutical industry over the last 11 years, has been spun out from Avantium Holding BV in a management buy-out to create Crystallics.

The new company will remain in Amsterdam, The Netherlands, and will specialize in solid state research and pre...

Plasticell Spins Out Regenerative Drug Discovery Venture Called

Wed, 13 Apr 2011 12:00:00 AM GMT

LONDON, UK, 13 April 2011 Plasticell Ltd, the biotechnology company developing high throughput stem cell technologies, has announced today that following its recent 3.5m financing, it has undergone a strategic re-structuring to enable the Company to focus on its award winning CombiCult technology for stem cell differentiation. Consequently, Plasticell Ltd has demerged its regenerative drug discovery...

BioTime and XenneX, Inc. Form to Create Roadmap for Regenerative Medicine

Wed, 06 Apr 2011 12:00:00 AM GMT

ALAMEDA, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has formed LifeMap Sciences, Inc., in collaboration with XenneX, Inc. LifeMap Sciences will develop and commercialize a database of the thousands of cell lineages branching from embryonic...

Generex Biotechnology Corporation to Spin Out Antigen Express, Inc., Names New CEO and CFO

Thu, 31 Mar 2011 12:00:00 AM GMT

WORCESTER, Mass. and TORONTO, March 30, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board:GNBT.ob - News) held a press conference earlier today at the NASDAQ Marketsite in New York City to unveil management's strategic development plan for the Company's future growth. A video of the press conference will be made available on the Generex website.

Pfizer Inc. Baby Food Commanding $6.8 Billion in Mead Johnson Nutrition Company Modeled Spinoff: Real M&A

Thu, 17 Mar 2011 12:00:00 AM GMT

Bloomberg -- Pfizer Inc. (PFE) investors are pushing for a spinoff of the drugmakers nutrition business that would command a price tag of $6.8 billion and deliver more than twice the gains of the U.S. stock market.

Phylogica Ltd. Forms Target Discovery Spin-Off, With Cambridge University

Wed, 09 Mar 2011 12:00:00 AM GMT

PERTH, AUSTRALIA AND CAMBRIDGE UK 9 March 2011 Leading Australian drug discovery company Phylogica Ltd (ASX: PYC, XETRA: PH7) will partner with researchers from the University of Cambridge in a spin-off company to pursue a novel application of its Phylomer peptides for discovery of disease-associated targets. The spin-off complements Phylogicas existing business model by opening up a new market...

China Cord Blood Corporation Forms Subsidiary

Tue, 22 Feb 2011 12:00:00 AM GMT

HONG KONG, Feb.22, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, today announced the formation of Zhejiang Lukou Biotechnology Co., Ltd. ("Zhejiang Lukou"), an indirect non-wholly owned subsidiary...

University of Strathclyde Spin-Out, to Apply New Technology for Tackling Infection

Fri, 21 Jan 2011 12:00:00 AM GMT

21 January 2011 -- A new company has been launched to commercialise an award-winning technology, developed at the University of Strathclyde in Glasgow, for tackling bacterial infection and contamination, including superbugs such as MRSA.

Fixed Phage Limited has been established to develop products based on its patented technology for treatment and prevention of infection and bacterial contamination...